A practical reference on selank: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-08-06 and is reviewed periodically as new material appears.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed as a stabilized analogue of tuftsin, a naturally occurring tetrapeptide fragment derived from the immunoglobulin heavy chain. The additional Pro-Gly-Pro segment at the carboxyl terminus is intended to slow enzymatic cleavage. The compound is usually described in the literature as a synthetic peptide with anxiolytic and cognitive-related activity, a label that reflects a research context rather than an approved therapeutic category.
Most published work on selank originates from a small number of research groups in the Russian Federation. A large share of that record appears in Russian-language journals, which limits access for readers who rely on English-indexed databases. Independent replication by laboratories outside the original research network is sparse in publicly available sources. This concentration of origin and language is a frequently noted feature when the compound is summarized in broader reviews of synthetic peptides.
Laboratory work relies on standard behavioral paradigms. Rodents are tested in the elevated plus maze, open field, and passive avoidance tasks, with outcomes compared against diazepam or vehicle controls. Intranasal dosing is used most often because it bypasses first-pass metabolism, though intraperitoneal and intravenous routes also appear in published protocols. Biochemical endpoints include tissue BDNF concentrations, cytokine levels, and monoamine metabolites. Human data are limited to small Russian trials reporting reduced anxiety scores; most were not prospectively registered, and few employed independent outcome assessment.
Measuring peptide exposure inside the brain is technically difficult. Selank is degraded rapidly in plasma, and assays must separate intact peptide from fragments, which favors targeted mass spectrometry over immunoassays alone. Reported half-lives are short, on the order of minutes, so effects observed hours later are attributed to downstream signaling rather than to the parent compound. Blood-brain barrier permeability is debated and rarely quantified directly. Gaps include absent dose-response characterization, inconsistent reporting of purity, and almost no pharmacokinetic data from human participants.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C33H57N11O9 | Derived from the seven-residue sequence |
| Molecular weight | About 751.9 g/mol | Average mass; the monoisotopic value is slightly lower |
| Residue count | Seven amino acids | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Parent compound | Tuftsin (Thr-Lys-Pro-Arg) | Selank extends tuftsin at the C-terminus |
| Compound class | Synthetic short peptide | Studied in a research setting; not a licensed drug in most markets |
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, frequently abbreviated as TKPRPGP. It was designed as a structural analogue of tuftsin, a naturally occurring tetrapeptide released by enzymatic cleavage of the immunoglobulin heavy chain. The two additional proline residues at the C-terminal end extend the parent chain and change how the molecule behaves in solution. The free peptide has a calculated molecular mass of approximately 751.9 g/mol and is generally supplied as a lyophilised white to off-white powder.
Development work on the compound began in the 1980s and 1990s at the Institute of Molecular Genetics in Moscow, within the same research programme that produced the peptide Semax. Early investigators sought a tuftsin derivative with improved resistance to enzymatic breakdown and with activity in the central nervous system after peripheral administration. Most of the primary literature from this period was published in Russian, a factor that still shapes how easily the findings can be checked by outside groups.
Naming for this compound is not fully standardised in English sources. The spelling Selanc appears in some transliterations, and catalogue entries may instead list the peptide sequence itself as the identifier. Reference material sometimes groups it with other short synthetic peptides studied for behavioural effects, which can create confusion when citations are compared. Distinguishing the exact sequence from related tuftsin analogues is therefore a practical first step when reviewing any dataset or specification sheet.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a structural analogue of tuftsin, a naturally occurring tetrapeptide fragment of the immunoglobulin heavy chain. The added Pro-Gly-Pro tail was intended to slow enzymatic degradation and extend biological activity. In Russia it is registered as an anxiolytic nasal preparation, while regulators elsewhere have not approved it for clinical use.
Proposed mechanisms centre on modulation of the GABAergic system, with reports of altered expression of genes related to GABA-A receptor subunits and changed monoamine turnover. Some studies describe inhibition of enkephalinase, the enzyme that degrades endogenous enkephalins, which may prolong opioid peptide signalling. Effects on brain-derived neurotrophic factor and on cytokine expression have also been reported. These findings come largely from animal models and small human studies, and the precise primary target remains unresolved.
Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.
Neutrophils are a type of phagocytic white blood cell and part of innate immunity. More specifically, they form the most abundant type of granulocytes and make up 40% to 70% of all white blood cells in humans. Their functions vary in different animals. In humans they participate in processes such as sterile inflammation, tissue repair, and cancer, and exhibit coordinated collective behavior. They are also known as neutrocytes, heterophils or polymorphonuclear leukocytes. They are formed from stem cells in the bone marrow and differentiated into subpopulations of neutrophil-killers and neutrophil-cagers. They are short-lived (between 5 and 135 hours) and highly mobile, as they can enter parts of tissue where other cells/molecules cannot. Neutrophils may be subdivided into segmented neutrophils and banded neutrophils (or bands). They form part of the polymorphonuclear cells family (PMNs) together with basophils and eosinophils. The name neutrophil derives from staining characteristics on hematoxylin and eosin (H&E) histological or cytological preparations. Whereas basophilic white blood cells stain dark blue and eosinophilic white blood cells stain bright red, neutrophils stain a neutral pink. Normally, neutrophils contain a nucleus divided into 2–5 lobes. Neutrophils are a type of phagocyte and are normally found in the bloodstream.
Noriega married Felicidad Sieiro in the late 1960s, and the couple had three daughters: Lorena; Sandra; and Thays. Sieiro had been a school teacher, and Noriega a member of the National Guard. Her family, of Basque heritage, was reported to have been unhappy with the marriage. Noriega was repeatedly unfaithful to his wife, who at one point expressed a desire for a divorce, though she changed her mind later.
=== Editing and producing === Phang has also edited and produced the feature film Target Audience 9.1 (2007), written and directed by Dominic Mah, produced the short film Sitter (2004) also written and directed by Dominic Mah, and served as executive producer for the short film Crazy Beats Strong Every Time (2011), directed and written by Moon Molson, and which was an official selection of the 2011 Sundance Film Festival. Phang also shares an editing credit on her 2015 feature Advantageous. Phang works closely with Premiere Pro and uses After Effects when dealing with VFX.
==== December 2023 ==== On 1 December, Hezbollah claimed five attacks on the Israel–Lebanon border. The IDF shelled Hula, killing two civilians, and the village of Jebbayn, killing an additional person. The IDF also struck a Hezbollah site and a Hezbollah cell preparing to carry out an attack near Malkia. Hezbollah announced the death of one of their members, presumably from one of the IDF strikes. The next day, Hezbollah fired several rockets at Israeli army posts along the border. Israel responded with airstrikes and artillery shelling against Hezbollah sites. Hezbollah stated that one of its fighters were killed. On 3 December, Hezbollah fired one anti-tank guided missile targeting an IDF base in Beit Hillel, injuring 11 Israelis and Global Affairs Canada announced that a Canadian citizen was killed in Lebanon. On 4 December, Hamas announced the creation of a new unit in Lebanon named the "Al-Aqsa Flood Vanguards" and called on "the youth and men of our people to join the vanguard resistance fighters and take part in shaping the future and liberating Jerusalem and the al-Aqsa Mosque." This created a negative reaction by many Lebanese politicians as they said that it would be a threat to Lebanon's sovereignty. One Lebanese soldier was killed and three others were injured by an Israeli attack on a Lebanese Army base in Odaisseh. The IDF later apologized for the incident, saying that it would investigate. A farm worker from Syria, was killed in an Israeli artillery attack on a poultry farm near Arnoun that also injured two of his relatives.
Sources: en.wikipedia.org
DH5-Alpha Cells are E. coli cells engineered by American biologist Douglas Hanahan to maximize transformation efficiency. They are defined by three mutations: recA1, endA1 which help plasmid insertion and lacZΔM15 which enables blue white screening. The cells are competent and often used with calcium chloride transformation to insert the desired plasmid. A study of four transformation methods and six bacteria strains showed that the most efficient one was the DH5 strain with the Hanahan method. The recA1 mutation is a single point mutation that replaces glycine 160 of the recA polypeptide with an aspartic acid residue in order to disable the activity of the recombinases and inactivate homologous recombination. The endA1 mutation inactivates an intracellular endonuclease to prevent it from degrading the inserted plasmid.
The isotopes 192Ir and 60Co are preferred for radiography, since iridium and cobalt are chemically non-reactive metals and can be obtained with much higher specific activities by the activation of stable 191Ir and 59Co in high-flux reactors. However, while 137Cs is a waste product produced in great quantities in nuclear fission reactors, 192Ir and 60Co are specifically produced in commercial and research reactors and their life cycle entails the destruction of the involved high-value elements. Cobalt-60 decays to stable nickel, whereas iridium-192 can decay to either stable osmium or platinum. Due to the residual radioactivity and legal hurdles, the resulting material is not commonly recovered even from "spent" radioactive sources, meaning in essence that the entire mass is "lost" for non-radioactive uses. As an almost purely synthetic isotope not existing in the environment before 1945, caesium-137 has been used to date wine and detect counterfeits and as a relative-dating material for assessing the age of sedimentation occurring after 1945. Caesium-137 is also used as a radioactive tracer in geologic research to measure soil erosion and deposition; its affinity for fine sediments is useful in this application.
=== Off-label drugs === Acetazolamide (Diamox) – carbonic anhydrase inhibitor Atomoxetine (Strattera) – norepinephrine reuptake inhibitor (NRI) Eszopiclone (Lunesta) – GABAA receptor positive allosteric modulator and nonbenzodiazepine/Z-drug Oxybutynin (Ditropan) – muscarinic acetylcholine receptor antagonist (anticholinergic) Pimavanserin (Nuplaizid) – serotonin 5-HT2A receptor antagonist Sodium oxybate (GHB; Xyrem) – GABAB receptor agonist and GHB receptor agonist Trazodone (Desyrel) – various actions Weight-loss drugs (e.g., liraglutide, semaglutide) – obesity-related sleep apnea
Sources: en.wikipedia.org
suffocating or roasting ants frying, roasting, toasting, suffocating, or drowning crickets eating aphids raw The website Insects Are Food suggests refrigerating insects to slow them down without killing them, prior to boiling or otherwise cooking them. Other guides recommend freezing first. Timothy Ferriss recounts what he observed when roasted his insects without freezing them first: "Suffice it to say, merely sedated crickets make horrible noises if you roast them, and the visual is far, far worse. Do yourself a favor and freeze them."
All records, in any form (including, but not limited to, written, electronic, magnetic, and optical records; and scans, x-rays, and electrocardiograms) that describe or record the methods, conduct, and/or results of a trial, the factors affecting a trial, and the actions taken. (ICH E6) Dose
=== Africa === The soybean first arrived in Africa via Egypt in 1857. Soya Meme (Baked Soya) is produced in the village called Bame Awudome near Ho, the capital of the Volta Region of Ghana, by the Ewe people of Southeastern Ghana and southern Togo.
Sources: en.wikipedia.org
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, designed as a metabolically stabilized analogue of the endogenous tetrapeptide tuftsin. It has been studied mainly against anxiety-related and cognitive endpoints rather than as an approved medicine in most jurisdictions.
Tuftsin contains four residues, while selank carries an additional Pro-Gly-Pro segment at the carboxyl end. That extension is intended to reduce enzymatic cleavage. Comparative pharmacokinetic data in humans remain limited.
No single receptor target is widely accepted as the definitive mediator of the reported effects. Proposed contributors include GABAergic modulation, shifts in monoamine turnover, and altered neuropeptide degradation. The mechanism is treated in the literature as unresolved.
Intranasal administration predominates in both animal and human research because it avoids hepatic first-pass metabolism. Injectable and intraperitoneal routes appear in animal work mainly for comparison.